Esophageal Temperature Management After Cardiac Arrest

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Cardiac Arrest
Interventions
DEVICE

Esophageal cooling device (and usual standard procedure)

Standard treatments for resuscitation after CA will follow local, national, and international guidelines. Core temperature is measured using urinary Foley catheters and/or arterial temperature monitoring if available. During TH, sedation and analgesia is performed in routine. Neuromuscular blockade is induced to favor cooling and prevent shivering if necessary. Circulatory function is monitored by arterial catheter if necessary and blood pressure is maintained as usually. Hypotension is treated with dobutamine catecholamines titrated according cardiac output monitored using echocardiogram, or PiCCO® systems. Fluid management is left at the discretion of the attending physician. Prognostication after CA uses serial clinical examinations, biomarkers, transcranial Doppler, Electro-Encephalo-Gram, cerebral CT-scan or MRI, and/or Somato-Sensory-Evoked-Potential.

Trial Locations (1)

75000

Lariboisère, Paris

All Listed Sponsors
collaborator

Advanced Cooling Therapy LLC, d/b/a Attune Medical

INDUSTRY

collaborator

Erik Kulstad, MD

UNKNOWN

lead

IST cardiology

INDUSTRY

NCT02327871 - Esophageal Temperature Management After Cardiac Arrest | Biotech Hunter | Biotech Hunter